retatrutide type 2 diabetes phase 2 trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a retatrutide type 2 diabetes trial

Normal GLP-1 side effects include mild nausea and fullness that typically improve within 48 weeks, while gastroparesis involves persistent symptoms beyond 12 weeks, vomiting of undigested food hours after meals, and severe impairment of nutritional intake requiring objective diagnosis via gastric emptying scintigraphy

Lyophilization (freeze-drying) removes water under low pressure so the peptide sublimates from solid to vapor, leaving a stable powder that preserves its integrity until it is reconstituted with bacteriostatic water

Adherence to the prescribed schedule is critical

Some degree of pain or discomfort during the process & for an average of 2-4 hours post treatment